The company invested in $30m (€27m) into the project to update the site, which is now able to offer biopharma development, drug product fill/finish services, and packaging.
The expansion of the Limoges site is expected to create up to 80 additional positions. Completion of the works arrives two years after the company announced the decision to invest into the 180,000-square-foot location.
As a result of the expansion, Catalent will be able to offer early phase integrated clinical development through to clinical supply services and small-scale commercial manufacturing. Within its network, the company can then take projects to other Catalent facilities for late-stage clinical or larger-scale commercial supply.
In terms of the equipment added by the capital injection, the company stated that a new small-to-mid-scale flexible filling line had been added, which is able to handle vials, syringes or cartridges. In addition, improvements have been made to analytical and quality control laboratories, with the facility also able to support clinical packaging and cold storage.
When asked about the scale of commercial capacity the facility is able to extend to, Bernie Clark, VP of marketing & strategy at Catalent Biologics, told BioPharma-Reporter: “The annual capacity of the new filling line, which is under a barrier isolator, is up to 10 million units. This output is dependent upon the product presentation and size of components.”
Meeting demand
Last year saw Catalent announce, in fourth quarter financials, that its biologics segment had been the top contributor to its overall financial performance, recording revenue growth of 66% and EBITDA doubling from the previous year’s quarter. A significant driver behind these results had been COVID-19 related projects.
"network" - Google News
March 22, 2022 at 04:03PM
https://ift.tt/d8DYrTI
Catalent completes $30m expansion to biologics network - BioPharma-Reporter.com
"network" - Google News
https://ift.tt/itXwK1O
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
No comments:
Post a Comment